NASDAQ: MIST
Milestone Pharmaceuticals Inc Stock Ownership - Who owns Milestone Pharmaceuticals?

Insider buying vs selling

Have Milestone Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MIST insiders and whales buy or sell their stock.

MIST Shareholders

What type of owners hold Milestone Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP8.89%7,571,204$20.29MInsider
Adage Capital Partners GP LLC8.19%6,976,000$18.70MInstitution
Propel Bio Management LLC6.02%5,124,890$13.73MInstitution
Orbimed Advisors LLC3.78%3,221,828$8.63MInstitution
Morgan Stanley3.49%2,969,067$7.96MInstitution
Simplify Asset Management Inc3.33%2,832,974$7.59MInstitution
Rtw Investments LP2.94%2,506,102$6.72MInstitution
Holdings A. Novo2.86%2,434,470$6.52MInsider
De Solidarite Des Travailleurs Du Quebec Fonds2.65%2,254,920$6.04MInsider
Pathstone Holdings LLC1.17%1,000,000$2.68MInstitution

1 of 3

MIST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIST40.08%15.55%
MDWD44.91%0.00%
HUMA24.49%16.42%Net Selling
EPRX35.63%0.00%
TNXP13.29%86.71%Net Buying

Milestone Pharmaceuticals Stock Ownership FAQ

Who owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals (NASDAQ: MIST) is owned by 40.08% institutional shareholders, 15.55% Milestone Pharmaceuticals insiders, and 44.37% retail investors. Rtw Investments LP is the largest individual Milestone Pharmaceuticals shareholder, owning 7.57M shares representing 8.89% of the company. Rtw Investments LP's Milestone Pharmaceuticals shares are currently valued at $20.29M.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.